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Available online 28 January 2015Abstract Embryonic pancreatic bud cells, the earliest pancreas-committed cells, generated from human embryonic stem cells
(hESCs) and induced pluripotent stem cells (hiPSCs) have been shown to differentiate intomature pancreaticβ-cells in vivo, indicating
the feasibility of hESC/iPSC-based cell therapy for diabetes. However, the key factors required for the differentiation of these cells
into pancreatic bud cells are incompletely understood. The purpose of this study was to establish culture conditions that efficiently
induce PDX1+NKX6.1+ pancreatic bud cells from hESCs/iPSCs. We differentiated a hESC line, KhES-3, into pancreatic lineages with a
stepwise protocol recapitulating developmental process. The induction rate of PDX1+NKX6.1+ cells was correlated with cell density in
adherent cultures, and markedly improved with cell aggregation cultures. The positive effects of cell aggregation cultures on the
differentiation of pancreatic bud cells were reproduced in multiple hESC/iPSC lines. The human PDX1+NKX6.1+ cells developed into
pancreatic epithelia after implantation into immunocompromised mice. Moreover, human C-peptide secretion into mouse
bloodstream was stimulated by glucose challenges after in vivo maturation. Taken together, these results suggest that cultures
with high cell density are crucial for the differentiation of pancreas-committed progenitor cells from hESCs/iPSCs. Our findingsmay be
applicable for the development of hESC/iPSC-based cell therapy for diabetes.
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Diabetes is caused by an absolute or relative insufficiency of
insulin which is secreted from pancreatic β-cells, resulting in
impaired glucose metabolism in the entire body (Mathis andn access article under the CC BY license
186 T. Toyoda et al.Vence, 2001; Donath and Halban, 2004). The supplementa-
tion of β-cell function is an effective therapeutic strategy,
but the insufficient cell supply is a major obstacle to this
intervention (Matsumoto, 2011). Therefore, vigorous efforts
have been made to develop a stable source of pancreatic
cells for clinical use.
Human embryonic stem cells (hESCs) and induced
pluripotent stem cells (hiPSCs) are attractive cell sources
due to their potential for unlimited proliferation and
differentiation (Dominguez-Bendala et al., 2011; McCall et
al., 2010). Indeed, a number of groups have generated
immature pancreatic β cell-like cells, which are referred to
as insulin-producing or insulin-secreting cells, from hESCs/
iPSCs in vitro (D'Amour et al., 2006; Jiang et al., 2007a,b;
Zhang et al., 2009; Nostro et al., 2011; Kroon et al., 2008;
Mfopou et al., 2010; Shim et al., 2007; Cai et al., 2010; Kelly
et al., 2011; Xu et al., 2011; Kunisada et al., 2012; Rezania
et al., 2011, 2012, 2013; Schulz et al., 2012; Bruin et al.,
2013; Sui et al., 2013). Despite the difficulties in generating
genuine β-cells in vitro, mature insulin-producing cells with
the potential for glucose responsiveness have been obtained
following the implantation of hESC-derived pancreatic
progenitors into immunodeficient mice (D'Amour et al.,
2006; Kroon et al., 2008; Shim et al., 2007; Kelly et al.,
2011; Rezania et al., 2012, 2013; Bruin et al., 2013).
Therefore, implantation of pancreatic progenitors, instead
of β-cells, is also considered to be a therapeutic option for
diabetes.
Previous reports have described the generation of
pancreatic lineage cells, such as pancreatic progenitors
and insulin-producing cells, from hESCs/iPSCs in vitro, using
stepwise differentiation protocols that recapitulate pancre-
atic development (D'Amour et al., 2006; Jiang et al., 2007a,
b; Zhang et al., 2009; Nostro et al., 2011; Kroon et al., 2008;
Mfopou et al., 2010; Shim et al., 2007; Cai et al., 2010; Kelly
et al., 2011; Xu et al., 2011; Kunisada et al., 2012; Rezania
et al., 2011, 2012, 2013; Schulz et al., 2012; Bruin et al.,
2013; Sui et al., 2013). However, the quantitative differ-
ences in the differentiation efficiency among hESC/iPSC
lines make it difficult to obtain the stable production of
pancreatic lineage cells with sufficient purity for use in the
clinical setting (Osafune et al., 2008). One of the solutions
for this is the establishment of stable differentiation
methods that can be more broadly applied to multiple
hESC/iPSC lines, based on a complete understanding of the
mechanisms of pancreatic organogenesis.
The major components of the pancreas are exocrine, duct
and endocrine cells, which originate from the endoderm
layer of early embryos marked by the co-expression of
transcription factors Sox17 and FoxA2 (Jennings et al.,
2013). The endodermal layer extends and folds to form the
primitive gut tube expressing Hnf1β and Hnf4α, which has
potential to differentiate into respiratory apparatus, diges-
tive tract and endocrine organs, including the pancreas.
Distinct pancreatic organogenesis morphologically starts at
the posterior foregut area in the primitive gut tube following
the expression of a transcription factor, Pdx1 (Jorgensen et
al., 2007; Jensen, 2004). Two parts of the Pdx1+ gut tube
thicken to form the dorsal and ventral pancreatic buds. It
should be noted that the early pancreatic epithelia formed
by the stratification of the single cell layer of the gut tube
and its protrusion into the surrounding mesenchyme exist asa three-dimensional highly-dense aggregate expressing
additional transcription factors, Ptf1a and Nkx6.1, during
the process of bud formation (Hald et al., 2008;
Ahnfelt-Ronne et al., 2012; Kawaguchi et al., 2002;
Villasenor et al., 2010). After that, microlumens appear
and fuse to form epithelial structures with a branched
tubular network within the aggregated pancreatic buds.
Some epithelia differentiate into hormone-producing endo-
crine lineages, such as insulin-secreting β-cells and
glucagon-secreting α-cells, and migrate into the mesen-
chyme to form pancreatic islets. Therefore, during the long
process of islet formation, cells experience dynamic struc-
tural changes.
The Pdx1 expression is first detected at the presumptive
bud area, maintained throughout the entire pancreatic
development and eventually localized to β- and δ-cells
(Jorgensen et al., 2007; Serup et al., 1995). However, the
Pdx1 expression is not exclusive to the pancreas in gut tube,
and extends anteriorly into the posterior stomach, duode-
num and biliary system in the middle of embryogenesis
(Jorgensen et al., 2007; Fukuda et al., 2006). On the other
hand, the expression of Nkx6.1 and Ptf1a is found only in
Pdx1+ pancreatic buds and these are specific for pancreatic
epithelium. Nkx6.1 and Ptf1a expression is eventually
restricted to β- and exocrine acinar cells, respectively
(Hald et al., 2008; Oster et al., 1998; Pan et al., 2013).
Therefore, pancreatic bud cells co-expressing Pdx1, Ptf1a
and Nkx6.1 are considered to be the earliest
pancreas-committed progenitors. In fact, the results of
implantation experiments have demonstrated that the
PDX1+NKX6.1+ cells are progenitors that specifically differ-
entiate into pancreatic cells (Kelly et al., 2011; Rezania et
al., 2013).
In the current study, we evaluated the morphological
characteristics of the pancreatic bud formation and tested
the hypothesis that a high cell density is a key factor
required to induce pancreatic bud cells in hESC/iPSC
cultures. For this purpose, we compared the induction
efficiency of the PDX1+NKX6.1+ cells in aggregation cultures
with that in planar culture conditions, and performed the
implantation of the PDX1+NKX6.1+ cells into immunocom-
promised mice to confirm whether the generated cells had
the potential to differentiate into pancreatic lineages in
vivo. We found that a high cell density is a crucial factor to
induce PDX1+NKX6.1+ pancreatic bud cells in vitro, which
can further differentiate into pancreatic epithelia and
mature into functional endocrine cells in vivo. We also
found that NKX6.1+ cells originated from PDX1high cells
among heterogeneous PDX1+ cell populations.Material and methods
In vitro differentiation of hESCs/iPSCs
The maintenance culture of a hESC line, KhES-3 (Suemori et
al., 2006), and five hiPSC lines; 585A1, 604B1, 692D2, 648B1
and 409B2 (Okita et al., 2011; Kajiwara et al., 2012) was
performed as described previously (Mae et al., 2013). For
feeder-free cultures, cells were maintained with Essential 8
medium (Thermo Fisher Scientific, Waltham, MA) according
to the manufacturer's instructions. Experiments with hESCs/
187Aggregation culture for pancreas inductioniPSCs were approved by the ethics committee of the
Department of Medicine and Graduate School of Medicine,
Kyoto University. Cells were directed into key stages of
pancreatic development, including definitive endoderm
(Stage 1), primitive gut tube (Stage 2), posterior foregutA
B
C
Figure 1 PDX1+NKX6.1+ cells are localized at aggregated area
differentiation of pancreatic bud cells from human ESCs. (B–D) A h
primitive gut tube endoderm, posterior foregut and pancreatic bud, a
(D) A magnified image of (C). Note that only the aggregated areas of
region Y)-box17; FOXA2, forkhead box protein A2; HNF, hepatocyt
GATA4, GATA binding protein 4; NKX6.1, NK6 transcription factor re(Stage 3) and pancreatic bud (Stage 4). The final protocol
was as follows (Fig. 1A):
Stage 1 hESC/iPSC colonies grown on a feeder layer were
first deprived of feeder cells and dissociated intoD
s. (A) A schematic diagram of the procedures used for the
ESC line, KhES-3, was differentiated into definitive endoderm,
nd was analyzed by immunostaining for representative markers.
PDX1high cells co-expressed NKX6.1. SOX17, SRY (sex determining
e nuclear factor; PDX1, pancreatic and duodenal homeobox 1;
lated, locus 1. Scale bars, 300 μm in B and 100 μm in C and D.
188 T. Toyoda et al.single cells as described previously (Suemori et al.,
2006). The cells were resuspended with Stage 1
medium containing RPMI 1640 medium (NACALAI
TESQUE, Kyoto, Japan) supplemented with 2%
(vol/vol) growth factor reduced B27 (GFR-B27,
Thermo Fisher Scientific), 50 U/ml penicillin/
streptomycin (P/S, Thermo Fisher Scientific),
100 ng/ml activin A (R&D Systems, Minneapolis,
MN), 3 μM CHIR99021 (Axon Medchem, Groningen,
Netherlands) and 10 μM Y-27632 (Wako, Osaka,
Japan), seeded on Matrigel (Becton Dickinson,
Franklin Lakes, NJ)-coated plates at a density of
1 × 105 cells/cm2 and cultured for one day. For
the next three days, the cells were cultured in
RPMI 1640 medium with 2% GFR-B27, 50 U/ml P/S,
100 ng/ml activin A and 1 μM CHIR99021.
Stage 2 The cells were exposed to Improved MEM Zinc
Option (iMEM) medium (Thermo Fisher Scientific)
supplemented with 1% GFR-B27, 100 U/ml P/S
(iMEM-B27) and 50 ng/ml keratinocyte growth
factor (KGF; R&D Systems) for three days.
Stage 3 The cultures were continued for three days in
iMEM-B27 with 0.5 μM 3-Keto-N-aminoethyl-N
′-aminocaproyldihydrocinnamoyl cyclopamine
(KAAD-CYC; Toronto Research Chemicals, Ontario,
Canada), 0.5 nM 4-[(E)-2-(5,6,7,8-Tetrahydro-
5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]
benzoic acid (TTNPB, Santa Cruz Biotechnology,
Dallas, TX) and 100 ng/ml NOGGIN (Pepro-tech,
Rocky Hill, NJ).
Stage 4 The cells were cultured for four to 20 days in
iMEM-B27 with 100 ng/ml KGF, 100 ng/ml
NOGGIN and 50 ng/ml epidermal growth factor
(EGF, R&D Systems). For monolayer and aggrega-
tion cultures, the cells after Stage 3 treatments
were dissociated into single cells by gentle
pipetting after treatment with 0.25% trypsin–
EDTA. The same inducing factors were used as
described above, except for the addition of
10 μM Y-27632 to the Stage 4 treatments. For
monolayer cultures, the cells were seeded on
Matrigel-coated plates at a density of 6–
48 × 104 cells/cm2. To evaluate various extracel-
lular matrices, the cells were seeded on
laminin-111 (10 μg/ml; BioLamina, Sundbyberg,
Sweden), fibronectin (5 μg/ml, Merck,
Whitehouse Station, NJ), Synthemax (Corning,
Corning, NY) and collagen I plates (Becton
Dickinson). For aggregation cultures, the cells
were seeded on a low-binding plate at a density
of 3–30 × 103 cells/well.Immunostaining
The cells were fixed with 4% paraformaldehyde (PFA) for
20 min at 4 °C. Then, immunostaining was performed as
described previously (Mae et al., 2013). The primary
antibodies used are detailed in Supplementary Table 1. The
cell aggregates or implanted grafts were fixed with 4% PFA
for one to two days at 4 °C. After washing with PBS, the
samples were equilibrated in a 10–30% sucrose solution atroom temperature for 1 h, and then mounted and frozen.
The frozen blocks were sectioned at 10–30 μm, and
immunostaining was performed after removing the mounting
medium. For quantification of the Ki-67+ and
cleaved-Caspase3+ cell ratios, immunostained cells were
analyzed using an image analyzer CellInsight NXT (Thermo
Fisher Scientific, Waltham, MA) or manual counting.Flow cytometry
The cells were dissociated into single cells with 0.25%
trypsin–EDTA treatment, fixed, permeabilized and blocked
with a BD Cytofix/Cytoperm Kit (Becton Dickinson). Then,
cells were stained with the antibodies detailed in Supple-
mentary Table 1.Quantitative real-time reverse transcription-
polymerase chain reaction (qRT-PCR)
Total RNA was isolated from the cells with an RNeasy kit
(Qiagen, Venlo, Netherlands), and cDNA was prepared with a
ReverTra Ace qPCR RT Master Mix (TOYOBO, Osaka, Japan)
and oligo (dT)20 primer, according to the manufacturer's
instructions. The qRT-PCR analysis was carried out with SYBR
Premix Ex Taq II (Takara, Otsu, Japan). The expression of
each gene was normalized to the level of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ex-
pression. The primer sequences used are shown in Supple-
mentary Table 2.Animal studies and transplantation experiments
All animal experiments were performed in accordancewith the
Guidelines for Animal Experiments of Kyoto University. Male
seven- to 14-week-old NOD.CB17-Prkdcscid/J mice (NOD–SCID,
Charles River Laboratories Japan, Yokohama, Japan) were
maintained on a 12-h light/dark cycle with ad libitum access to
a standard irradiated diet. Mice were anesthetized with
inhalable isoflurane and received implants of hESC-derived
cell aggregates after Stage 4. Stage 4 day 4 cell aggregates
(30 × 103 cells/aggregate) were cultured in Stage 4 medium
with or without an ALK5 inhibitor (Santa Cruz) for one to two
additional days before implantation. Then, two hundred cell
aggregates per mouse were implanted under a kidney
subcapsule. At 30–210 days after implantation, the mice
were sacrificed and the serial sections of grafts were examined
by immunostaining, as described above.
The graft function was assessed by measuring human
C-peptide levels in mouse plasma in response to glucose
administration. The mice were fasted for N5 h, and a 30%
glucose solution was administered by intraperitoneal injec-
tion at a dose of 3.0 g/kg body weight. Blood samples were
collected prior to and at 30 min after the glucose adminis-
tration via a tail vein into heparinized capillaries. The
plasma human C-peptide level was analyzed by an ELISA
(Mercodia, Uppsala, Sweden), according to the
manufacturer's instructions. All metabolic analyses were
performed in conscious and restrained animals.
189Aggregation culture for pancreas inductionStatistical analysis
The statistical analyses were performed using paired t-tests
(SigmaStat 3.5, Systat, San Jose, CA). The differences
between groups were considered significant for values of
p b 0.05.Results
hESC-derived PDX1+NKX6.1+ cells are formed at
aggregated areas of adhesion cultures
To examine the differentiation of PDX1+NKX6.1+ pancreatic
bud-like cells from a hESC line, KhES-3, we developed a
directed differentiation protocol with a monolayer culture
format bymodifying the previously reportedmethods (Kunisada
et al., 2012; Schulz et al., 2012) (Fig. 1A). As analyzed by
immunostaining for representative markers for each step, we
effectively obtained cells of the definitive endoderm
(SOX17+FOXA2+), gut tube endoderm (HNF4α+HNF1β+) and
posterior foregut (PDX1+HNF6+ or PDX1+GATA4+) (Fig. 1B).
Further differentiation of hESC-derived posterior foregut
toward the pancreatic bud yielded only a small number of
PDX1+NKX6.1+ cells. Most NKX6.1+ cells were located in the
aggregated areas composed of cells showing bright PDX1
fluorescent signals, whereas the PDX1+NKX6.1− cells were
mostly found in the remaining monolayered areas (Figs. 1C and
D). The areas of PDX1+NKX6.1+ cells were expanded gradually
around the aggregates (data not shown), thus indicating their
further differentiation into PDX1+NKX6.1+ cells or the prolifer-
ation of PDX1+NKX6.1+ cells within the aggregates. Our
observation of PDX1+NKX6.1+ cells in the aggregated areas of
adhesion cultures was reminiscent of the pancreatic budding in
mouse embryos (Jorgensen et al., 2007).
Aggregation cultures efficiently differentiate hESC-
derived PDX1+ foregut into PDX1+NKX6.1+
pancreatic buds
Next, to investigate whether cell aggregation itself is a
factor to promote NKX6.1+ cell differentiation, the PDX1+
cells on culture day 10 were either treated with Stage 4
factors (S4F), or were dissociated and treated with Stage 4
factors in monolayer cultures at different cell densities (6–
48 × 104 cells/cm2) (S4F-2D) or in suspension cultures with
cellular aggregates of different sizes (3–30 × 103 cells/
aggregate) (S4F-AG) (Fig. 2A). On day 14, the S4F cells
showed a mixture of aggregated and monolayered areas,
while the cells treated with the S4F-2D formed monolayers
without any aggregated areas (Fig. 2B). Before the induction
on day 10, there were no PDX1+NKX6.1+ cells (Fig. 2C). The
S4F cultures generated PDX1+NKX6.1+ cells at an 18 ± 5%
induction rate. On the other hand, the induction rate of
PDX1+NKX6.1+ cells was consistently lower (3–17%) in the
S4F-2D cultures in a coating with various extracellular
matrices (Fig. S1), and there was a tendency for the rate
to increase as the cell density increased. Notably, the much
higher induction rate of PDX1+NKX6.1+ cells (38–40%) was
consistently obtained with the S4F-AG cultures, regardless
of the size, compared with the S4F-2D cultures.To validate themRNA expression of pancreatic budmarkers
in the S4F-AG cultures (hereafter described as aggregation
cultures), we performed qRT-PCR analyses at each time point
during Stage 4. The PDX1 expression was increased in
aggregation cultures shortly after the start of Stage 4, while
the expression level was not changed in the S4F-2D cultures
(hereafter described as monolayer cultures) (Fig. 2D). The
expression of pancreatic bud-specific markers, PTF1A and
NKX6.1, also began to increase one day after the start of
Stage 4, and progressively increased in aggregation cultures,
while the expression in monolayer cultures remained extreme-
ly low.
The positive effects of aggregation cultures on the
differentiation of pancreatic bud cells were reproduced in
multiple hiPSC lines (585A1, 604B1, 648B1, 692D2 and
409B2), in addition to a hESC line, KhES-3 (Fig. 2E). These
results suggest that high cell density cultures with cellular
aggregation promoted the differentiation of multiple hESC/
iPSC cell lines into pancreatic bud cells.PDX1+NKX6.1+ cells emerge from PDX1high cells in
cellular aggregates
In our adhesion culture, we found that there was heterogene-
ity of the PDX1+ cells in terms of the expression levels (Fig. 1D).
We therefore performed flow cytometric analyses of the cell
populations in cellular aggregates after 0–20 days of Stage 4
treatments to determine the origin of the NKX6.1+ cells.
Before the Stage 4 treatments, around 80% of the cells were
PDX1+, and the majority was PDX1middle or PDX1low. However,
within one day after the Stage 4 treatments, the majority of
the cells became PDX1high. On day 2, the PDX1high cells started
to diverge into two populations: one population expressing
NKX6.1 and the other showing downregulation of the PDX1
expression (Fig. 3A). The ratio of PDX1+NKX6.1+ cells was
significantly increased during the first four to eight days of
Stage 4, and reached around 90% on days 12–20 (Fig. 3B). The
PDX1+NKX6.1+ cell ratio was similar regardless of the aggre-
gate size (Fig. S2). These results imply that the lineage
commitment to PDX1+NKX6.1+ cells occurs between days 2
and 8.
Next, we investigated the localization of PDX1+NKX6.1+
cells in the cellular aggregates. Immunostaining on cryosec-
tions of aggregates on days 4 and 12 of Stage 4 revealed that
PDX1+NKX6.1+ cells were uniformly distributed inside aggre-
gates (Figs. 4A and B). Notably, most PDX1high cells were
PDX1+NKX6.1+ and were co-stained for GATA4 and SOX9,
other markers for the pancreatic bud (Jennings et al., 2013).
As occurs during in vivo pancreatic development, the
PDX1+NKX6.1+ cell areas were stratified to become thick-
ened by day 12 (Fig. 4B), suggesting that the increase in the
PDX1+NKX6.1+ cell ratio on days 4–20 might be mainly due to
the proliferation of these cells. In fact, the total cell
numbers were increased by 2-fold on culture day 12 in
Stage 4 compared with that observed on days 1–4 (Fig. S3).
Insulin+ (INS+) cells were one component of the
PDX1+NKX6.1− cells. These INS+ cells were PDX1low, and
some of them were glucagon+ (GCG+). There were some INS−
GCG+ cells, some ghrelin+ (GHR+) cells and some somato-
statin+ (SST+) cells, suggesting the lineage commitment into
immature fetal endocrine cells (Rezania et al., 2012).
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Figure 2 Cell aggregation cultures promote PDX1+NKX6.1+ cell induction from PDX1+ posterior foregut cells. (A) A schematic
diagram of the procedures used to assess the effects of the cell density on the cultures with regard to the induction of pancreatic bud
cells. Posterior foregut cells differentiated in adhesion cultures were treated with the soluble factors required for pancreatic bud
induction (KGF, NOGGIN and EGF), either with only a medium change (S4F) or with re-seeding at different cell densities for monolayer
cultures (6–48 × 104 cells/cm2, S4F-2D) or to form cellular aggregates (3–30 × 103 cells/aggregate) (S4F-AG). (B) Representative
bright field images of the three culture formats. (C) Quantification of the PDX1+NKX6.1+ cell ratio. After the induction of pancreatic
bud cells in the three culture conditions described above, cells were examined by flow cytometry. (D) The mRNA expression of
pancreatic bud markers, PDX1, PTF1A and NKX6.1, was assessed by quantitative real-time polymerase chain reaction (qRT-PCR)
before and during pancreatic bud induction with cell aggregation (black circle, solid line) and in monolayer cultures (open circle,
dotted line). The data are presented as the fold-change in gene expression relative to the peak value. (E) A hESC line (KhES-3) and
five hiPSC lines (585A1, 604B1, 692D2, 648B1 and 409B2) were differentiated into posterior foregut cells in adhesion cultures. Then,
the foregut cells were dissociated, re-seeded either for monolayer cultures (12 × 104 cells/cm2, 2D) or to form cellular aggregates
(3 × 103 cells/aggregate, AG) and were treated with KGF, NOGGIN and EGF to induce pancreatic bud cells. After the differentiation,
the PDX1+NKX6.1+ cell ratio was measured by flow cytometry. The data are presented as the mean ± S.E.M. from three to seven
independent experiments in C and from three independent experiments in D and E. Scale bar, 300 μm.
190 T. Toyoda et al.
Days during Stage 4
Ce
ll r
at
io
 (%
)
B
0 21 4 12
NKX6.1+
PD
X1
+
Days during Stage 4
A
0 4 8 12 16 20
0
10
20
30
40
50
60
70
80
90
100
Figure 3 PDX1+NKX6.1+ cells emerge from PDX1high cells in cellular aggregates. Cell populations were analyzed by flow cytometry
after 0–20 days of aggregation culture at Stage 4. (A) Representative dot plots indicating that NKX6.1+ cells emerged from PDX1high
cells. (B) Quantification of the induction rate of PDX1+NKX6.1+ (black circle, solid line) and the total PDX1+ cells (open circle, dotted
line). The data are from three independent experiments presented as the mean ± S.E.M.
191Aggregation culture for pancreas inductionThe commitment to PDX1+NKX6.1+ cells requires
both cell aggregation and soluble factors
A novel protocol combining the treatment with three soluble
factors (KGF, NOGGIN and EGF) and cell aggregation cultures
was established to efficiently induce the PDX1+NKX6.1+ cells in
this study. Three soluble factorswere also effective in inducing
the NKX6.1 gene expression in the adhesion cultures (S4F)
(Schulz et al., 2012) (Fig. S4). To investigate whether the
signals elicited by aggregation cultures were independent of
those induced by the three factors, we examined the effects of
all combinations of the factors on the NKX6.1 expression after
four-day treatments with aggregation cultures. The cellular
aggregates did not express NKX6.1 without any factor
treatments, while the expression was increased by the
treatments with each single factor or each combination of
two factors out of the three, and the expression was highest
when the cells were treated with all three factors (Fig. 5A).
These data suggest that the signals elicited by aggregation
cultures are independent of those induced by the three
factors.
To determine the timing of the soluble factor treatments
required for PDX1+NKX6.1+ cell commitment, cellular aggre-
gates were cultured for 12 days, and NOGGIN or all three
factors were removed for either the last four or eight days.
The removal of NOGGIN did not significantly change the
PDX1+NKX6.1+ cell ratio on day 12 (Fig. 5B). On the other
hand, the removal of all three factors for the last four oreight days slightly decreased the PDX1+NKX6.1+ cell ratio on
day 12, but the ratio was still increased compared to that
before the removal. These results suggest that the cell fate
commitment into PDX1+NKX6.1+ cells induced by soluble
factors occurred by day 4 of Stage 4.
In order to examine whether the selection for
PDX1+NKX6.1+ cell progenitors leads to an increase in the
ratio of PDX1+NKX6.1+ cells in aggregation cultures, we
performed time course analyses of the proliferating and
apoptotic cells at Stage 4. The levels of proliferative cells
were increased and few cells were apoptotic in the S4F and
S4F-2D cultures (Fig. S5). The apoptotic cell ratio tended to
be higher in the S4F-AG culture in the early periods of Stage
4 compared with that observed in the S4F and S4F-2D
cultures. The apoptotic cell ratio decreased, while the
proliferating cell ratio increased, with time in the S4F-AG
culture. More apoptotic cells were found among the PDX1−
cells than the PDX1+ cells in the S4F-AG cultures, suggesting
that the selection of PDX1+ cells may be a mechanism
underlying the increased rate of induction of PDX1+NKX6.1+
cells (Fig. S5D).PDX1+NKX6.1+ cells differentiate into pancreatic
epithelia in vivo
We next examined the developmental potential of the
PDX1+NKX6.1+ cells generated with aggregation cultures to
INS GCG Nuclei
GATA4 NKX6.1
PDX1 NKX6.1PDX1 Nuclei
PDX1 SOX9
PDX1 INS
SST NKX6.1 GHRINS NKX6.1
INS GCG Nuclei
GATA4 NKX6.1
PDX1 NKX6.1PDX1 Nuclei
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SST NKX6.1 GHR INS NKX6.1
B
A
Figure 4 PDX1+NKX6.1+ cells in cellular aggregates co-express multiple pancreatic bud markers. The localization of PDX1+NKX6.1+
cells in aggregates was assessed. Cryosections of cellular aggregates at Stage 4, days 4 (A) and 12 (B), were stained for the indicated
markers of pancreatic buds (PDX1, NKX6.1, SOX9 and GATA4) and endocrine cells (INS, GCG, SST and GHR). Pancreatic bud cells were
distributed throughout the entire aggregates, and were segregated from endocrine compartments. SOX9, SRY (sex determining region
Y)-box9; INS, insulin; GCG, glucagon; SST, somatostatin; GHR, ghrelin. Scale bar, 100 μm.
192 T. Toyoda et al.differentiate into pancreatic cells in vivo by implanting the
cell aggregates on days 4–5 of Stage 4 into kidney subcapsule
of immunocompromised mice. Thirty days after implanta-
tion, the aggregates had fused together to become single
grafts (Fig. 6A). In contrast to the uniform distribution
pattern of PDX1+ cells inside aggregates before implantation
(Fig. 4), PDX1+ cells were well-aligned and formed tubular
structures, which were observed throughout the entire
grafts (Figs. 6B and C). There were INS+ cells budding from
tubular structures, as well as endocrine cell clusters
(Fig. 6D), which were reminiscent of human embryonic
pancreatic epithelia (Riedel et al., 2012). Most INS+ cells
were polyhormonal, co-expressing GCG, SST and GHR,
without forming islet-like structures or co-expressing
NKX6.1, and showed lower PDX1 expression levels compared
with the surrounding tubular cells, thus indicating thegeneration of immature endocrine cells. Some PDX1+ cells
were not NKX6.1+ but GATA4+, implying the segregation of
endocrine and exocrine lineages. These branched epithelial
structures derived from implanted aggregates were ob-
served in three independent experimental cohorts treated
with KhES-3 hESCs (seven out of seven mice) and one
independent cohort treated with 585A1 hiPSCs (one out of
one mouse) (Fig. S6).
To confirm the differentiation potential of PDX1+NKX6.1+
cells into mature pancreatic β-cells, we examined plasma
human C-peptide levels in host mice and the response to
different blood glucose levels. To obtain a larger number of
pancreatic β-cells in vivo, cellular aggregates were
pre-treated with an ALK5 inhibitor before implantation,
since this treatment was previously reported to promote the
differentiation into β-cells (Rezania et al., 2012). We found
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Figure 5 Both cell aggregation cultures and soluble factor
treatment are required for the efficient induction of PDX1+NKX6.1+
cells. (A) NKX6.1 expression was assessed by qRT-PCR in the cells
treated with various combinations of soluble factors (100 ng/ml
KGF, 100 ng/ml NOGGIN and 50 ng/ml EGF) for four days of Stage 4
aggregation culture. Cell aggregation alone did not induce the
expression of NKX6.1. Treatment with all soluble factors with
aggregation cultures most potently induced the expression of
NKX6.1. (B) NOGGIN or all of the soluble factors (KGF, NOGGIN and
EGF) was/were removed at the indicated periods during 12 days of
aggregation culture at Stage 4. (Upper) A schematic diagram of the
procedures used to assess the specific timing requirements for the
soluble factors. (Lower) The quantification of the induction rate of
PDX1+NKX6.1+ (black bars) and PDX1+NKX6.1− (white bars) cells.
The data are from three independent experiments presented as
the mean ± S.E.M. n/a, not applicable.
193Aggregation culture for pancreas inductionthat there was an about 10% increase in the NKX6.1+ cell
ratio by pre-treatment with the ALK5 inhibitor (data not
shown). The human C-peptide levels in mouse plasma were
gradually increased over time (Fig. 7A), and human
C-peptide was detected in 11 out of 13 mice by 150 days
after implantation (one mouse died before day 150). Wefound a similar tendency for a gradual increase in the human
C-peptide levels in mice that underwent the implantation of
cellular aggregates without the pre-treatment with an ALK5
inhibitor (data not shown). Moreover, we obtained grafts
which were capable of responding to the changes in blood
glucose levels by 150 days (Fig. 7B). There were also
islet-like INS+ cell clusters found inside the grafts, which
did not co-express GCG on day 210 after implantation
(Fig. 7C). These results suggest that the pancreatic cells
generated with aggregation cultures have the developmen-
tal potential to differentiate into pancreatic epithelia and
mature into β-cells in vivo.Discussion
It has recently been demonstrated that hESCs/iPSCs can be
differentiated into pancreatic lineages that show therapeu-
tic potential for diabetes (Rezania et al., 2012, 2013; Bruin
et al., 2013). Although the inducing factors have been
intensively explored, the most suitable conditions to
generate pancreatic cells have not yet been fully
established. The obstacles preventing the establishment of
such conditions include the different propensities for
directed differentiation among hESC/iPSC lines (Osafune et
al., 2008). We herein demonstrated that aggregation
cultures efficiently induced the differentiation of pancreatic
bud cells in multiple hESC/iPSC lines.
During embryonic development, the lineage commitment
into the pancreas occurs at the step of pancreatic bud
formation, in which Pdx1+ cells form clusters and start
expressing Ptf1a and Nkx6.1. A previous report utilized a
rotational suspension-based differentiation method to gen-
erate PDX1+NKX6.1+ pancreatic bud progenitors from a hESC
line, CyT49 (Schulz et al., 2012). Their use of cell
aggregation cultures throughout the differentiation process
from the undifferentiated state resulted in the efficient
induction of PDX1+NKX6.1+ cells. Consistent with that study,
we found that a higher cell density led to more efficient
generation of PDX1+NKX6.1+ cells. Although the current
model does not directly address the molecules responsible
for these findings, the previous works and our current study
allow us to hypothesize that a high cell density acts as a
factor to activate the essential signals for the differentiation
of posterior foregut cells into pancreatic bud.
Our findings suggest that the signals elicited by a high cell
density or their surrogate stimuli are potent inducers of the
directed differentiation of hESCs/iPSCs into pancreatic
lineages. The efficient generation of PDX1+NKX6.1+ cells
with adherent culture conditions in another report (Rezania
et al., 2012) may have resulted from the acquisition of the
signals due to the culture conditions or because the cell lines
used intrinsically possessed the signals. Indeed, the in-
creased cell number observed in Stage 1 resulted in a higher
cell density at Stage 4, thus producing more efficient
induction of NKX6.1+ cells in the adherent cultures without
re-seeding at Stage 4 (S4F; Supplementary Table 3). This
result supports the idea that a high cell density is a key
factor for pancreatic bud induction. We reason that
unknown factors, including cell density factors, acting at
specific times explain the variation in the differentiation
efficiency noted in the different research groups. In the
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Figure 6 The PDX1+NKX6.1+ cells generated with aggregation cultures differentiate into branched pancreatic epithelia in vivo.
Cellular aggregates at Stage 4, days 4–5, were implanted into the kidney subcapsules of NOD–SCID mice. (A) An image of a host kidney
harvested 30 days after implantation. The arrow indicates the location of the graft. (B–D) Cryosections of grafts were stained for the
indicated markers. Representative images of human pancreatic cells are shown. Asterisks indicate the host mouse kidney in B and C.
HuN, human nuclei. Scale bars, 100 μm in B and D and 300 μm in C.
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cells at Stage 4, day 5, of aggregation cultures that had been pre-treated with an ALK5 inhibitor were implanted under the kidney
subcapsule of NOD–SCID mice. (A) The average plasma human C-peptide levels in host mice were measured 30 min after glucose
injection (3.0 g/ kg body weight, i.p.) at various time points after implantation, as indicated. (B) The average plasma human
C-peptide levels after N5 h of fasting (before) and 30 min after glucose injection (after) in the host mice were examined on day 150
after implantation. (C) A representative image of hESC-derived islet-like endocrine clusters on day 210 after implantation. The data
are presented as the mean ± S.E.M. of 13 mice from four independent cohorts of implantation experiments in A and four mice from
two independent cohorts of implantation experiments in B. *P b 0.05. Scale bar, 100 μm.
195Aggregation culture for pancreas inductionpresent study, the induction rates of PDX1+NKX6.1+ cells
were lower with some cell lines than with a hESC line,
KhES-3. One plausible explanation is the low induction
efficiency of cells in the steps before aggregation formation,
such as definitive endoderm or posterior foregut cells. The
optimization of culture conditions for these steps could
make further contributions to resolving the problems of
line-to-line variation of hESCs/iPSCs.
Although the detailed mechanisms underlying the in-
crease in PDX1+NKX6.1+ cell induction in aggregation
cultures remain unknown, this finding raises the possibility
that pancreatic bud formation may be regulated by the
molecules associated with contact-dependent cellular inter-
actions, such as extracellular matrices and adhesion mole-
cules, and other membrane-bound receptors (Brafman et
al., 2013; Crisera et al., 2000; Ekblom et al., 1998). Possible
mechanisms include the involvement of laminin–integrin
signaling. During pancreatic development, epithelial cell
delamination and migration into mesenchyme is the early
event in the differentiation process into endocrine cells
(Villasenor et al., 2012). However, we found that the
expression levels of pan-laminin were similar between
NKX6.1+ cells and NKX6.1− cells in both aggregation and
monolayer cultures (data not shown). Although we could not
exclude the possibility that laminin isoforms are different
between the cell populations, we assumed that typical
laminin–integrin signals are not likely to be directly
involved. In addition, based on the findings obtained with
the other extracellular matrices (Fig. S1), at a minimum,
laminin-111, vitronectin (main component of Synthemax),
fibronectin and collagen I are not likely to be involved.
Instead, other cell surface-derived signals, such as those
associated with the apicobasal polarity (Villasenor et al.,
2010; Kesavan et al., 2009) and planar cell polarity pathways
(Cortijo et al., 2012), or unknown autocrine/paracrine
molecules, may be involved. Further studies with compara-
tive analyses of the gene expression profiles between 2D and
aggregation cultures would be helpful to elucidate the
factors responsible for the regulation of NKX6.1 induction in
developing pancreatic buds.It is possible that the signals elicited by a high cell density
increased the ratio of PDX1+NKX6.1+ cells via the direct
induction of differentiation into PDX1+NKX6.1+ cells, while
the selective proliferation of progenitor cells and/or
selective apoptosis of uncommitted cells are also possible
mechanisms. The number of proliferating cells was low on
days 1–2 in Stage 4, during which time the PDX1+NKX6.1+
cells emerged in the cell aggregation cultures (Figs. S5A and
C). In addition, the total cell number in the aggregation
cultures was not increased at Stage 4, days 1–2, suggesting
the involvement of selective proliferation to be less likely
(Fig. S3). On the other hand, the number of apoptotic cells
was increased in the cellular aggregates, consistent with the
idea that aggregation cultures selectively delete cells
uncommitted to the PDX1+NKX6.1+ cell lineage (Figs. S5B
and D). In fact, more apoptotic cells were found within the
PDX1− cell population (Fig. S5D), which suggests that
selective apoptosis is a possible mechanism. In the future,
the identification of marker genes for pancreatic cells
uncommitted to NKX6.1+ cells and application of subsequent
live cell imaging with the reporter cell line of the marker
would help to clearly demonstrate the involvement of
selective apoptosis in the increased PDX1+NKX6.1+ cell
ratio observed in high-density cultures.
It was previously reported that the activation of BMP
signaling facilitates the proliferation of NKX6.1+ cells (Sui et
al., 2013). In contrast, our data indicate that the inhibition by
adding NOGGIN increased the NKX6.1 expression (Fig. 5A).
Consistent with our findings, other reports have demonstrated
that NKX6.1+ pancreatic progenitors were generated under
continuous suppression of BMP signaling in hESC differentia-
tion cultures (Rezania et al., 2012, 2013; Schulz et al., 2012;
Bruin et al., 2013), and that the phosphorylation of smad1/5/
8, downstream effectors of BMP signaling, was suppressed in
Nkx6.1+ cells from developing chick pancreatic buds
(Ahnfelt-Ronne et al., 2010). In addition, the BMP inhibition
by in ovo gene transfer of Noggin into the presumptive
pancreatic region of chick embryos resulted in pancreatic
bud formation without further branching and epithelialization
(Ahnfelt-Ronne et al., 2010). We reasoned that BMP inhibition
196 T. Toyoda et al.is involved in the commitment to NKX6.1+ cells, but that BMP
signaling is necessary for the subsequent proliferation and
differentiation. In agreement with this, we found that the
induction rate of PDX1+NKX6.1+ cells was continuously
increased with the removal of NOGGIN after day 4 of Stage 4
(Fig. 5B). Although BMP activation may expand NKX6.1+ cells,
we assume that the first four days of aggregation cultures are
critical for the commitment of PDX1+NKX6.1+ cells, and that
all three factors are beneficial for the PDX1+NKX6.1+ cell
induction.
In summary, the cell density of PDX1+ posterior foregut
cells positively correlates with the induction of PDX1+NKX6.1+
pancreatic bud cells in hESC/iPSC differentiation cultures.
Although the molecules that regulate the differentiation step
remain unknown, the signals elicited by high cell density are
crucial for the pancreatic bud induction, and synergistically
work with soluble factors. To our knowledge, this is the first
study clearly demonstrating that the signals derived from
spatial and morphological contexts are associated with the
differentiation of hESCs/iPSCs into pancreatic lineages.
Further studies to elucidate the molecular nature of the
signals based on our findings may contribute to the develop-
ment of hESC/iPSC-based cell therapy for diabetes.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2015.01.007.
Acknowledgments
This work was supported in part by funding from the Takeda
Science Foundation to T.T., the Suzuken Memorial Founda-
tion to T.T. and the Life Science Foundation of Japan to
K.O., by the Japan Society for the Promotion of Science
(JSPS) through its ‘Funding Programme for World-Leading
Innovative R&D on Science and Technology (FIRST Pro-
gramme)’ to K.O. and Grant-in-Aid for Young Scientists (B)
to T.T. and by the Japan Science and Technology Agency
(JST) through its research grant “Core Center for iPS Cell
Research and Projects for Technological Development,
Research Center Network for Realization of Regenerative
Medicine” to Y.K. and K.O. T.T. wrote the first draft of the
manuscript. T.T., S.M., Y.K. and K.O. contributed to
manuscript edits and revisions. T.T., S.M., Y.K., M.F.,
Y.H., Y.K. and K.O. designed, directed, and interpreted
the experiments. T.T., S.M., H.T. and T.S. performed the
experiments. K.O. supervised the study. The authors thank
Kanae Mitsunaga for her technical assistance in the flow
cytometry analysis and Yasuhiro Nakano for providing
valuable advice on this research.References
Ahnfelt-Ronne, J., Ravassard, P., Pardanaud-Glavieux, C.,
Scharfmann, R., Serup, P., 2010. Mesenchymal bone morphoge-
netic protein signaling is required for normal pancreas develop-
ment. Diabetes 59, 1948–1956.
Ahnfelt-Ronne, J., Jorgensen, M.C., Klinck, R., Jensen, J.N.,
Fuchtbauer, E.M., Deering, T., MacDonald, R.J., Wright, C.V.,
Madsen, O.D., Serup, P., 2012. Ptf1a-mediated control of Dll1
reveals an alternative to the lateral inhibition mechanism.
Development 139, 33–45.Brafman, D.A., Phung, C., Kumar, N., Willert, K., 2013. Regulation of
endodermal differentiation of human embryonic stem cells
through integrin–ECM interactions. Cell Death Differ. 20, 369–381.
Bruin, J.E., Rezania, A., Xu, J., Narayan, K., Fox, J.K., O'Neil, J.J.,
Kieffer, T.J., 2013. Maturation and function of human embryonic
stem cell-derived pancreatic progenitors in macroencapsulation
devices following transplant into mice. Diabetologia 56,
1987–1998.
Cai, J., Yu, C., Liu, Y., Chen, S., Guo, Y., Yong, J., Lu, W., Ding, M.,
Deng, H., 2010. Generation of homogeneous PDX1(+) pancreatic
progenitors from human ES cell-derived endoderm cells. J. Mol.
Cell Biol. 2, 50–60.
Cortijo, C., Gouzi, M., Tissir, F., Grapin-Botton, A., 2012. Planar
cell polarity controls pancreatic beta cell differentiation and
glucose homeostasis. Cell Rep. 2, 1593–1606.
Crisera, C.A., Kadison, A.S., Breslow, G.D., Maldonado, T.S., Longaker,
M.T., Gittes, G.K., 2000. Expression and role of laminin-1 in mouse
pancreatic organogenesis. Diabetes 49, 936–944.
D'Amour, K.A., Bang, A.G., Eliazer, S., Kelly, O.G., Agulnick, A.D.,
Smart, N.G., Moorman, M.A., Kroon, E., Carpenter, M.K.,
Baetge, E.E., 2006. Production of pancreatic hormone-
expressing endocrine cells from human embryonic stem cells.
Nat. Biotechnol. 24, 1392–1401.
Dominguez-Bendala, J., Inverardi, L., Ricordi, C., 2011. Stem cell-
derived islet cells for transplantation. Curr. Opin. Organ
Transplant. 16, 76–82.
Donath, M.Y., Halban, P.A., 2004. Decreased beta-cell mass in
diabetes: significance, mechanisms and therapeutic implica-
tions. Diabetologia 47, 581–589.
Ekblom, M., Falk, M., Salmivirta, K., Durbeej, M., Ekblom, P., 1998.
Laminin isoforms and epithelial development. Ann. N. Y. Acad.
Sci. 857, 194–211.
Fukuda, A., Kawaguchi, Y., Furuyama, K., Kodama, S., Kuhara, T.,
Horiguchi, M., Koizumi, M., Fujimoto, K., Doi, R., Wright, C.V.,
Chiba, T., 2006. Loss of the major duodenal papilla results in
brown pigment biliary stone formation in pdx1 null mice.
Gastroenterology 130, 855–867.
Hald, J., Sprinkel, A.E., Ray, M., Serup, P., Wright, C., Madsen,
O.D., 2008. Generation and characterization of Ptf1a antiserum
and localization of Ptf1a in relation to Nkx6.1 and Pdx1 during
the earliest stages of mouse pancreas development.
J. Histochem. Cytochem. 56, 587–595.
Jennings, R.E., Berry, A.A., Kirkwood-Wilson, R., Roberts, N.A.,
Hearn, T., Salisbury, R.J., Blaylock, J., Piper Hanley, K., Hanley,
N.A., 2013. Development of the human pancreas from foregut to
endocrine commitment. Diabetes 62, 3514–3522.
Jensen, J., 2004. Gene regulatory factors in pancreatic develop-
ment. Dev. Dyn. 229, 176–200.
Jiang, W., Shi, Y., Zhao, D., Chen, S., Yong, J., Zhang, J., Qing, T.,
Sun, X., Zhang, P., Ding, M., Li, D., Deng, H., 2007a. In vitro
derivation of functional insulin-producing cells from human
embryonic stem cells. Cell Res. 17, 333–344.
Jiang, J., Au, M., Lu, K., Eshpeter, A., Korbutt, G., Fisk, G.,
Majumdar, A.S., 2007b. Generation of insulin-producing islet-
like clusters from human embryonic stem cells. Stem Cells 25,
1940–1953.
Jorgensen, M.C., Ahnfelt-Ronne, J., Hald, J., Madsen, O.D., Serup,
P., Hecksher-Sorensen, J., 2007. An illustrated review of early
pancreas development in the mouse. Endocr. Rev. 28, 685–705.
Kajiwara, M., Aoi, T., Okita, K., Takahashi, R., Inoue, H.,
Takayama, N., Endo, H., Eto, K., Toguchida, J., Uemoto, S.,
Yamanaka, S., 2012. Donor-dependent variations in hepatic
differentiation from human-induced pluripotent stem cells.
Proc. Natl. Acad. Sci. U. S. A. 109, 12538–12543.
Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R.J.,
Wright, C.V., 2002. The role of the transcriptional regulator
Ptf1a in converting intestinal to pancreatic progenitors. Nat.
Genet. 32, 128–134.
197Aggregation culture for pancreas inductionKelly, O.G., Chan, M.Y., Martinson, L.A., Kadoya, K., Ostertag,
T.M., Ross, K.G., Richardson, M., Carpenter, M.K., D'Amour,
K.A., Kroon, E., Moorman, M., Baetge, E.E., Bang, A.G., 2011.
Cell-surface markers for the isolation of pancreatic cell types
derived from human embryonic stem cells. Nat. Biotechnol. 29,
750–756.
Kesavan, G., Sand, F.W., Greiner, T.U., Johansson, J.K., Kobberup,
S., Wu, X., Brakebusch, C., Semb, H., 2009. Cdc42-mediated
tubulogenesis controls cell specification. Cell 139, 791–801.
Kroon, E., Martinson, L.A., Kadoya, K., Bang, A.G., Kelly, O.G.,
Eliazer, S., Young, H., Richardson, M., Smart, N.G.,
Cunningham, J., Agulnick, A.D., D'Amour, K.A., Carpenter,
M.K., Baetge, E.E., 2008. Pancreatic endoderm derived from
human embryonic stem cells generates glucose-responsive
insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443–452.
Kunisada, Y., Tsubooka-Yamazoe, N., Shoji, M., Hosoya, M., 2012.
Small molecules induce efficient differentiation into insulin-
producing cells from human induced pluripotent stem cells.
Stem Cell Res. 8, 274–284.
Mae, S., Shono, A., Shiota, F., Yasuno, T., Kajiwara, M., Gotoda-
Nishimura, N., Arai, S., Sato-Otubo, A., Toyoda, T., Takahashi,
K., Nakayama, N., Cowan, C.A., Aoi, T., Ogawa, S., McMahon,
A.P., Yamanaka, S., Osafune, K., 2013. Monitoring and robust
induction of nephrogenic intermediate mesoderm from human
pluripotent stem cells. Nat. Commun. 4, 1367.
Mathis, D., Vence, L., Benoist, C., 2001. Beta-cell death during
progression to diabetes. Nature 414, 792–798.
Matsumoto, S., 2011. Clinical allogeneic and autologous islet cell
transplantation: update. Diabetes Metab. J. 35, 199–206.
McCall, M.D., Toso, C., Baetge, E.E., Shapiro, A.M., 2010. Are stem
cells a cure for diabetes? Clin. Sci. (Lond.) 118, 87–97.
Mfopou, J.K., Chen, B., Mateizel, I., Sermon, K., Bouwens, L., 2010.
Noggin, retinoids, and fibroblast growth factor regulate hepatic
or pancreatic fate of human embryonic stem cells. Gastroenter-
ology 138, 2233–2245 (2245 e2231–2214).
Nostro, M.C., Sarangi, F., Ogawa, S., Holtzinger, A., Corneo, B., Li,
X., Micallef, S.J., Park, I.H., Basford, C., Wheeler, M.B., Daley,
G.Q., Elefanty, A.G., Stanley, E.G., Keller, G., 2011. Stage-
specific signaling through TGFbeta family members and WNT
regulates patterning and pancreatic specification of human
pluripotent stem cells. Development 138, 861–871.
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A.,
Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K.,
Shibata, T., Kunisada, T., Takahashi, M., Takahashi, J., Saji, H.,
Yamanaka, S., 2011. A more efficient method to generate
integration-free human iPS cells. Nat. Methods 8, 409–412.
Osafune, K., Caron, L., Borowiak, M., Martinez, R.J., Fitz-Gerald,
C.S., Sato, Y., Cowan, C.A., Chien, K.R., Melton, D.A., 2008.
Marked differences in differentiation propensity among human
embryonic stem cell lines. Nat. Biotechnol. 26, 313–315.
Oster, A., Jensen, J., Serup, P., Galante, P., Madsen, O.D., Larsson,
L.I., 1998. Rat endocrine pancreatic development in relation to
two homeobox gene products (Pdx-1 and Nkx 6.1). J. Histochem.
Cytochem. 46, 707–715.
Pan, F.C., Bankaitis, E.D., Boyer, D., Xu, X., Van de Casteele, M.,
Magnuson, M.A., Heimberg, H., Wright, C.V., 2013. Spatiotem-
poral patterns of multipotentiality in Ptf1a-expressing cells
during pancreas organogenesis and injury-induced facultative
restoration. Development 140, 751–764.
Rezania, A., Riedel, M.J., Wideman, R.D., Karanu, F., Ao, Z.,
Warnock, G.L., Kieffer, T.J., 2011. Production of functionalglucagon-secreting alpha-cells from human embryonic stem
cells. Diabetes 60, 239–247.
Rezania, A., Bruin, J.E., Riedel, M.J., Mojibian, M., Asadi, A., Xu, J.,
Gauvin, R., Narayan, K., Karanu, F., O'Neil, J.J., Ao, Z.,
Warnock, G.L., Kieffer, T.J., 2012. Maturation of human
embryonic stem cell-derived pancreatic progenitors into func-
tional islets capable of treating pre-existing diabetes in mice.
Diabetes 61, 2016–2029.
Rezania, A., Bruin, J.E., Xu, J., Narayan, K., Fox, J.K., O'Neil, J.J.,
Kieffer, T.J., 2013. Enrichment of human embryonic stem cell-
derived NKX6.1-expressing pancreatic progenitor cells acceler-
ates the maturation of insulin-secreting cells in vivo. Stem Cells
31, 2432–2442.
Riedel, M.J., Asadi, A., Wang, R., Ao, Z., Warnock, G.L., Kieffer,
T.J., 2012. Immunohistochemical characterisation of cells co-
producing insulin and glucagon in the developing human
pancreas. Diabetologia 55, 372–381.
Schulz, T.C., Young, H.Y., Agulnick, A.D., Babin, M.J., Baetge, E.E.,
Bang, A.G., Bhoumik, A., Cepa, I., Cesario, R.M., Haakmeester,
C., Kadoya, K., Kelly, J.R., Kerr, J., Martinson, L.A., McLean,
A.B., Moorman, M.A., Payne, J.K., Richardson, M., Ross, K.G.,
Sherrer, E.S., Song, X., Wilson, A.Z., Brandon, E.P., Green, C.E.,
Kroon, E.J., Kelly, O.G., D'Amour, K.A., Robins, A.J., 2012. A
scalable system for production of functional pancreatic progen-
itors from human embryonic stem cells. PLoS One 7, e37004.
Serup, P., Petersen, H.V., Pedersen, E.E., Edlund, H., Leonard, J.,
Petersen, J.S., Larsson, L.I., Madsen, O.D., 1995. The
homeodomain protein IPF-1/STF-1 is expressed in a subset of
islet cells and promotes rat insulin 1 gene expression dependent
on an intact E1 helix–loop–helix factor binding site. Biochem. J.
310 (Pt 3), 997–1003.
Shim, J.H., Kim, S.E., Woo, D.H., Kim, S.K., Oh, C.H., McKay, R.,
Kim, J.H., 2007. Directed differentiation of human embryonic
stem cells towards a pancreatic cell fate. Diabetologia 50,
1228–1238.
Suemori, H., Yasuchika, K., Hasegawa, K., Fujioka, T., Tsuneyoshi,
N., Nakatsuji, N., 2006. Efficient establishment of human
embryonic stem cell lines and long-term maintenance with
stable karyotype by enzymatic bulk passage. Biochem. Biophys.
Res. Commun. 345, 926–932.
Sui, L., Geens, M., Sermon, K., Bouwens, L., Mfopou, J.K., 2013.
Role of BMP signaling in pancreatic progenitor differentiation
from human embryonic stem cells. Stem Cell Rev. 9, 569–577.
Villasenor, A., Chong, D.C., Henkemeyer, M., Cleaver, O., 2010.
Epithelial dynamics of pancreatic branching morphogenesis.
Development 137, 4295–4305.
Villasenor, A., Marty-Santos, L., Dravis, C., Fletcher, P.,
Henkemeyer, M., Cleaver, O., 2012. EphB3 marks delaminating
endocrine progenitor cells in the developing pancreas. Dev. Dyn.
241, 1008–1019.
Xu, X., Browning, V.L., Odorico, J.S., 2011. Activin, BMP and FGF
pathways cooperate to promote endoderm and pancreatic
lineage cell differentiation from human embryonic stem cells.
Mech. Dev. 128, 412–427.
Zhang, D., Jiang, W., Liu, M., Sui, X., Yin, X., Chen, S., Shi, Y.,
Deng, H., 2009. Highly efficient differentiation of human ES cells
and iPS cells into mature pancreatic insulin-producing cells. Cell
Res. 19, 429–438.
